Lv3
384 积分 2021-12-09 加入
Effects of sodium-glucose contrasporter-2 inhibitors and glucagon-like peptide-1 receptor agonists on arterial stiffness, coronary flow reserve and liver steatosis in diabetes
8天前
已完结
Effects of sodium-glucose contrasporter-2 inhibitors and glucagon-like peptide-1 receptor agonists on vascular function and liver steatosis in diabetes
8天前
已完结
Effects of tofogliflozin and glimepiride in liver histology on nonalcoholic fatty liver disease with type 2 diabetes
8天前
已完结
Impact of oral anti-diabetes medication on liver fat in type 2 diabetes mellitus and non alcoholic fatty liver: RCT
8天前
已关闭
Serum Thrombospondin-2 Level as a Novel Liver Fibrosis Biomarker That Changes with Liver Stiffness Improvement in Patients with Type 2 Diabetes
8天前
已完结
Pilot randomized controlled trial of effects of dapagliflozin and vit E on MASLD with type 2 DM
8天前
已完结
Serum high-molecular-weight adiponectin and response to dapagliflozin in patients with type 2 diabetes and non-alcoholic fatty liver disease
8天前
已完结
Serum Thrombospondin-2 Level as a Novel Liver Fibrosis Biomarker That Changes with Liver Stiffness Improvement in Patients with Type 2 Diabetes
8天前
已关闭
Effect of Empagliflozin for the Treatment of Nonalcoholic Steatohepatitis in Patients with Type 2 DM
8天前
已完结
皖公网安备34019202002308
